Cutaneous small-vessel vasculitis (CSVV) refers to a group of disorders usually characterized by palpable purpura; it is caused by leukocytoclastic vasculitis of postcapillary venules. CSVV can be idiopathic or can be associated with a drug, infection, or underlying systemic disease. Initially, the pathogenesis of CSVV is immune complex related, but in its later stages different pathogenetic mechanisms may intensify the reaction and lymphocytes may predominate in the infiltrate. Cure requires elimination of the cause (ie, drugs, chemicals, infections, food allergens) when possible, as well as therapy with nonsteroidal antiinflammatory agents, corticosteroids, dapsone, potassium iodide, fibrinolytic agents, aminocaproic acid, immunosuppressive agents (ie, cyclophosphamide, azathioprine, methotrexate, cyclosporine) or even monoclonal antibodies, depending on disease severity. (J Am Acad Dermatol 1998;39:667-87.) Learning Objective: At the conclusion of this learning activity, participants should have a firm understanding of the cause, pathogenesis, clinical features, and treatment of CSVV.
Le texte complet de cet article est disponible en PDF.
American Academy of Dermatology, Inc. Publié par Elsevier Masson SAS. Tous droits réservés.